XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health... Show more
XOMA is expected to report earnings to fall 466.67% to -21 cents per share on August 06
Q2'25
Est.
$-0.22
Q1'25
Beat
by $0.35
Q4'24
Beat
by $0.25
Q3'24
Missed
by $1.15
Q2'24
Beat
by $1.10
The last earnings report on May 13 showed earnings per share of 5 cents, beating the estimate of -28 cents. With 18.64K shares outstanding, the current market capitalization sits at 296.30M.